Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition-Reference-Cited by-同舟云学术

Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition

Published:2013-10-10 Issue:12 Volume:104 Page:1593-1599
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sakogawa Kenji¹²,Aoki Yoshiro¹²,Misumi Keizo¹²,Hamai Yoichi²,Emi Manabu²,Hihara Jun²,Shi Lin¹,Kono Kazuteru¹,Horikoshi Yasunori¹,Sun Jiying¹,Ikura Tsuyoshi³,Okada Morihito²,Tashiro Satoshi¹

Affiliation:

1. Department of Cellular Biology; Research Institute for Radiation Biology and Medicine; Hiroshima University; Hiroshima Japan

2. Department of Surgical Oncology; Research Institute for Radiation Biology and Medicine; Hiroshima University; Hiroshima Japan

3. Department of Mutagenesis; Radiation Biology Center; Kyoto University; Kyoto Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.12281/fullpdf

Reference44 articles.

1. Genome maintenance mechanisms for preventing cancer;Hoeijmakers;Nature,2001

2. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

3. Role of poly (ADP-ribose) formation in DNA repair;Satoh;Nature,1992

4. Post-translational modification of poly (ADP-ribose) polymerase induced by DNA strand breaks;Lindahl;Trends Biochem Sci,1995

5. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions;D′Amours;Biochem J,1999

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel dual action PARP and microtubule polymerization inhibitor AMXI-5001 powerfully inhibits growth of esophageal carcinoma both alone and in combination with radiotherapy;American Journal of Cancer Research;2024

2. Reversal of Cisplatin Resistance in Ovarian Cancer by the Multitargeted Nanodrug Delivery System Tf-Mn-MOF@Nira@CDDP;ACS Applied Materials & Interfaces;2023-05-23

3. Effect of the PARP inhibitor veliparib on germ cell tumor cell lines;Oncology Letters;2022-09-21

4. Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers;Biomedicines;2021-08-16

5. Unsymmetric Cisplatin-Based Pt(IV) Conjugates Containing a PARP-1 Inhibitor Pharmacophore Tested on Malignant Pleural Mesothelioma Cell Lines;Molecules;2021-08-05